Development of consensus treatment plans for juvenile localized scleroderma: A roadmap toward comparative effectiveness studies in juvenile localized scleroderma

Arthritis Care and Research

Volumn 64, Issue 8, 2012, Pages 1175-1185

  Li, Suzanne C ^a   Torok, Kathryn S ^b   Pope, Elena ^c   Dedeoglu, Fatma ^d   Hong, Sandy ^e   Jacobe, Heidi T ^f   Rabinovich, C Egla ^g   Laxer, Ronald M ^c   Higgins, Gloria C ^h   Ferguson, Polly J ^e   Lasky, Andrew ⁱ   Baszis, Kevin ^j   Becker, Mara ⁱ   Campillo, Sarah ^k   Cartwright, Victoria ^l   Cidon, Michael ^m   Inman, Christi J ⁿ   Jerath, Rita ^o   O'Neil, Kathleen M ^p   Vora, Sheetal ^q   Zeft, Andrew ^r   Wallace, Carol A ^s   Ilowite, Norman T ^t   Fuhlbrigge, Robert C ^d   more..

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF TEXAS AT DALLAS   (United States)

^g DUKE UNIVERSITY   (United States)

^h NATIONWIDE CHILDREN S HOSPITAL   (United States)

ⁱ Children's Mercy Hospital   (United States)

^j WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k MCGILL UNIVERSITY   (Canada)

^l LEGACY EMANUEL MEDICAL CENTER   (United States)

^m LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

ⁿ UNIVERSITY OF UTAH   (United States)

^o MEDICAL COLLEGE OF GEORGIA   (United States)

^p UNIVERSITY OF OKLAHOMA   (United States)

^q MEDICAL COLLEGE OF WISCONSIN   (United States)

^r LERNER RESEARCH INSTITUTE   (United States)

^s SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^t CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE;

ARTHRITIS; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE EFFECTIVENESS; CONSENSUS DEVELOPMENT; COUGHING; DYSPNEA; ERYTHEMA; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HAIR LOSS; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; JUVENILE LOCALIZED SCLERODERMA; LOCALIZED SCLERODERMA; SKIN ATROPHY; SKIN INDURATION; SKINFOLD THICKNESS; TREATMENT PLANNING; TREATMENT RESPONSE; VASCULITIC RASH;

ADOLESCENT; CONSENSUS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METHOTREXATE; METHYLPREDNISOLONE; PRACTICE GUIDELINES AS TOPIC; PROGRAM DEVELOPMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864451477     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21687     Document Type: Article

References (43)

1. Fett N, Werth VP,. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 2011; 64: 217-28.
2. Scalapino K, Arkachaisri T, Lucas M, Fertig N, Helfrich DJ, Londino AV Jr, et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol 2006; 33: 1004-13.
3. Nelson A,. Localized scleroderma including morphea, linear scleroderma, and eosinophilic fasciitis. Curr Probl Pediatr 1996; 26: 318-24.
4. Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J, et al, for the Juvenile Scleroderma Working Group of the Pediatric Rheumatology European Society (PRES). Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 2005; 52: 2873-81.
5. Marzano A, Menni S, Parodi A, Borghi A, Fuligni A, Fabbri P, et al. Localized scleroderma in adults and children: clinical and laboratory investigations on 239 cases. Eur J Dermatol 2003; 13: 171-6.
6. Weibel L, Sampaio M, Visentin M, Howell K, Woo P, Harper J,. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children. Br J Dermatol 2006; 155: 1013-20.
7. Mirsky L, Chakkittakandiyil A, Laxer RM, O'Brien C, Pope E,. Relapse after systemic treatment in paediatric morphoea. Br J Dermatol 2012; 166: 443-5.
8. Saxton-Daniels S, Jacobe HT,. An evaluation of long-term outcomes in adults with pediatric-onset morphea. Arch Dermatol 2010; 146: 1044-5.
9. Peterson L, Nelson A, Su W, Mason T, O'Fallon W, Gabriel S,. The epidemiology of morphea (localized scleroderma) in Olmstead County 1960-1993. J Rheumatol 1997; 24: 73-80.
10. Christen-Zaech S, Hakim M, Afsar F, Paller A,. Pediatric morphea (localized scleroderma): review of 136 patients. J Am Acad Dermatol 2008; 59: 385-96.
11. Wu EY, Rabinovich EC, Torok KS, Li SC, Fuhlbrigge RC, CARRANet Investigators. Description of the Localized Scleroderma Subgroup of CARRA net Registry [abstract]. Arthritis Rheum 2011; 63 Suppl: S787-8.
12. Chung L, Lin J, Furst D, Fiorentino D,. Systemic and localized scleroderma. Clin Dermatol 2006; 24: 374-92.
13. Fett N, Werth V,. Update on morphea: part II. Outcome measures and treatment. J Am Acad Dermatol 2011; 64: 231-42.
14. Vilela FA, Carneiro S, Ramos-e-Silva M,. Treatment of morphea or localized scleroderma: review of the literature. J Drugs Dermatol 2010; 9: 1213-9.
15. Li S, Feldman B, Higgins G, Haines K, Punaro M, O'Neil K,. Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists. J Rheumatol 2010; 37: 175-81.
16. Zulian F, Martini G, Vallongo C, Vittadello F, Falcini F, Patrizi A, et al. Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2011; 63: 1998-2006.
17. Uziel Y, Feldman BM, Krafchik BR, Yeung RS, Laxer RM,. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr 2000; 136: 91-5.
18. Zwischenberger B, Jacobe H,. A systematic review of morphea treatments and therapeutic algorithm. J Am Acad Dermatol 2011; 65: 925-41.
19. Hunzelmann N, Scharffetter Kochanek K, Hager C, Krieg T,. Management of localized scleroderma. Semin Cutan Med Surg 1998; 17: 34-40.
20. Zulian F,. New developments in localized scleroderma. Curr Opin Rheumatol 2008; 20: 601-7.
21. Dytoc M, Ting P, Man J, Sawyer D, Fiorillo L,. First case series on the use of imiquimod for morphoea. Br J Dermatol 2004; 153: 815-20.
22. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281-5.
23. Arkachaisri T, Pino S,. Localized scleroderma severity index and global assessments: a pilot study of outcome instruments. J Rheumatol 2008; 35: 650-7.
24. Nair R, Aggarwal R, Khanna D,. Methods of formal consensus in classification/diagnostic criteria and guideline development. Semin Arthritis Rheum 2011; 41: 95-105.
25. Arkachaisri T, Vilaiyuk S, Li S, O'Neil KM, Pope E, Higgins GC, et al. The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures. J Rheumatol 2009; 36: 2819-29.
26. Li SC, Torok KS, Pope E, Stewart KG, Higgins GC, Rabinovich EC, et al. Development of a clinical disease activity measure for juvenile localized scleroderma [abstract]. Arthritis Rheum 2011; 63 Suppl: S955-6.
27. Laxer R, Zulian F,. Localized scleroderma. Curr Opin Rheumatol 2006; 18: 606-13.
28. Zulian F, Vallongo C, de Oliveira S, Punaro M, Ros J, Mazur-Zielinska H, et al. Congenital localized scleroderma. J Pediatr 2006; 149: 248-51.
29. Kreuter A, Gambichler T, Breuckmann F, Rotterdam S, Freitag M, Stuecker M, et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. Arch Dermatol 2005; 141: 847-52.
30. Seyger M, van den Hoogen F, de Boo T, de Jong E,. Low-dose methotrexate in the treatment of widespread morphea. J Am Acad Dermatol 1998; 39: 220-5.
31. Torok KS, Arkachaisri T,. Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study. J Rheumatol 2012; 39: 286-94.
32. Beltramelli M, Vercellesi P, Frasin A, Gelmetti C, Corona F,. Localized severe scleroderma: a retrospective study of 26 pediatric patients. Pediatr Dermatol 2010; 27: 476-80.
33. Fitch P, Rettig P, Burnham J, Finkel T, Yan A, Akin E, et al. Treatment of pediatric localized scleroderma with methotrexate. J Rheumatol 2006; 33: 609-14.
34. Kawashima H, Watanabe C, Kashiwagi Y, Sato S, Ioi H, Sasamoto M, et al. Therapy of childhood generalized morphea: case reports and reviews of the literature of Japanese cases. Pediatr Int 2006; 48: 342-5.
35. Osminina MK, Geppe NA, Tougarinova GV, Rabieva GM, Kostina YO,. Efficacy and safety of methotrexate treatment of juvenile localized scleroderma. Pediatr Rheumatol 2008; 6 Suppl: 230.
36. Cox D, O'Regan G, Collins S, Byrne A, Irvine A, Watson R,. Juvenile localised scleroderma: a retrospective review of response to systemic treatment. Ir J Med Sci 2008; 177: 343-6.
37. Kroft E, Creemers M, van den Hoogen F, Boezeman J, de Jong E,. Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study. Br J Dermatol 2009; 160: 1075-82.
38. Walsh J, Martini G, Woo P, Black C, Murray K,. Evaluation and treatment of childhood onset localised scleroderma 1988- 1999 [abstract]. Arch Dis Child 2000; 82 Suppl: A44.
39. Hedrich C, Flebig B, Hahn G, Suttorp M, Gahr M,. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease. Clin Pediatr 2011; 50: 604-14.
40. Joly P, Bamberger N, Crickx B, Belaich S,. Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients. Arch Dermatol 1994; 130: 663-4.
41. Martini G, Ramanan A, Falcini F, Girschick H, Goldsmith D, Zulian F,. Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil. Rheumatology (Oxford) 2009; 48: 1410-3.
42. Arkachaisri T, Vilaiyuk S, Torok K, Medsger T Jr,. Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study. Rheumatology (Oxford) 2010; 49: 373-81.
43. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A,. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997; 40: 1202-9.